What is Trastuzumab-DTTB: Uses, Dosage, Side Effects and More

Trastuzumab-DTTB is a targeted cancer medication that helps treat certain types of breast cancer and stomach cancer. It works by blocking specific proteins that fuel cancer growth, giving your immune system a better chance to fight the disease.

This medication belongs to a group called monoclonal antibodies, which are lab-made proteins designed to target cancer cells specifically. Think of it as a guided missile that seeks out and attacks only the cancer cells while leaving most healthy cells alone.

What is Trastuzumab-DTTB?

Trastuzumab-DTTB is a biosimilar version of the original trastuzumab medication. A biosimilar means it's nearly identical to the original drug but made by a different manufacturer, offering you the same benefits at potentially lower costs.

The medication specifically targets cancer cells that have too much of a protein called HER2. About 15-20% of breast cancers and some stomach cancers have this HER2 protein in high amounts, which makes the cancer grow faster and spread more aggressively.

Your doctor will test your cancer tissue to see if it has high levels of HER2 before recommending this treatment. Only cancers that test positive for HER2 will respond to this medication.

What is Trastuzumab-DTTB Used For?

Trastuzumab-DTTB treats HER2-positive breast cancer and HER2-positive stomach cancer. It can be used whether your cancer has spread to other parts of your body or is still contained in one area.

For breast cancer, doctors often use this medication in several situations. You might receive it after surgery to prevent cancer from coming back, or alongside chemotherapy if your cancer has spread to lymph nodes or other areas.

In stomach cancer cases, this medication typically works alongside chemotherapy to help shrink tumors and slow cancer progression. Your healthcare team will determine the best combination of treatments based on your specific situation.

How Does Trastuzumab-DTTB Work?

Trastuzumab-DTTB works by attaching to the HER2 protein on cancer cells and blocking signals that tell the cancer to grow. This is considered a moderately strong targeted therapy that specifically fights HER2-positive cancers.

Once attached to the HER2 protein, the medication sends signals to your immune system to attack those cancer cells. It also prevents the cancer cells from receiving growth signals they need to multiply and spread.

The medication doesn't work like traditional chemotherapy that affects all rapidly dividing cells. Instead, it focuses specifically on cancer cells with the HER2 protein, which means it typically causes fewer side effects than broader cancer treatments.

How Should I Take Trastuzumab-DTTB?

Trastuzumab-DTTB is given through an IV (intravenous) infusion at a hospital or cancer treatment center. You cannot take this medication at home, as it requires careful monitoring by healthcare professionals.

Your first infusion will take about 90 minutes, while subsequent doses usually take about 30-60 minutes. The medication is mixed with a saline solution and dripped slowly into your bloodstream through a needle in your arm or through a port if you have one.

You don't need to eat specific foods before treatment, but staying well-hydrated by drinking plenty of water can help your body handle the medication better. Some people find it helpful to eat a light meal beforehand to prevent nausea.

Your healthcare team will monitor you closely during each infusion and for at least an hour afterward. They'll check your vital signs and watch for any immediate reactions to the medication.

How Long Should I Take Trastuzumab-DTTB For?

The length of treatment with trastuzumab-DTTB depends on your specific type of cancer and treatment goals. Most people receive treatment for about one year, which typically means getting infusions every three weeks.

If you're getting this medication to prevent breast cancer from returning after surgery, you'll likely receive it for 12 months total. This timeline has been shown to provide the best balance of benefits while minimizing long-term side effects.

For advanced or metastatic cancer, you might continue treatment for as long as it's helping control your cancer and you're tolerating it well. Your doctor will regularly check how your cancer is responding and adjust your treatment plan accordingly.

Never stop taking this medication without talking to your healthcare team first. Even if you're feeling better, completing the full course of treatment gives you the best chance of keeping cancer from returning.

What Are the Side Effects of Trastuzumab-DTTB?

Most people experience some side effects with trastuzumab-DTTB, but they're often manageable with proper support and monitoring. The most common side effects are generally mild to moderate and improve over time.

Here are the side effects you might experience, starting with the most common ones:

• Fatigue and feeling tired more than usual
• Headaches that may come and go
• Nausea and occasional vomiting
• Diarrhea or changes in bowel movements
• Muscle and joint aches
• Fever and chills, especially after the first few infusions
• Skin rash or irritation at the infusion site

These common side effects usually become less bothersome as your body adjusts to the medication. Your healthcare team can provide medications and strategies to help manage these symptoms effectively.

Some people may experience more serious side effects that require immediate medical attention. While these are less common, it's important to know what to watch for:

• Heart problems, including shortness of breath or chest pain
• Severe allergic reactions during or shortly after infusion
• Signs of infection, such as persistent fever or unusual weakness
• Severe lung problems, including persistent cough or difficulty breathing
• Significant swelling in your legs, ankles, or face

Your doctor will monitor your heart function regularly throughout treatment, as this medication can sometimes affect how well your heart pumps blood. Most people don't develop serious heart problems, but early detection allows for quick treatment adjustments if needed.

Who Should Not Take Trastuzumab-DTTB?

Trastuzumab-DTTB isn't suitable for everyone, and your doctor will carefully review your medical history before recommending this treatment. People with certain heart conditions may not be able to safely receive this medication.

You should not receive trastuzumab-DTTB if you have a known severe allergic reaction to trastuzumab or any of its ingredients. Your doctor will also be cautious if you have a history of serious heart problems or significantly reduced heart function.

If you're pregnant or planning to become pregnant, this medication can harm your developing baby. Your healthcare team will discuss effective birth control options with you during treatment and for several months after your last dose.

People with active serious infections may need to wait until the infection is controlled before starting treatment. Your immune system needs to be strong enough to handle both fighting infection and receiving cancer treatment.

Trastuzumab-DTTB Brand Names

Trastuzumab-DTTB is available under the brand name Ogivri. This is the biosimilar version that offers the same effectiveness as the original trastuzumab medication but often at a lower cost.

The original trastuzumab medication goes by the brand name Herceptin. Both medications work the same way and have similar side effects, so your doctor might use either one based on availability and your insurance coverage.

Some treatment centers may refer to this medication simply as "trastuzumab" in your treatment plan, regardless of which specific brand they're using. The important thing is that you're receiving the right medication for your HER2-positive cancer.

Trastuzumab-DTTB Alternatives

Several other medications can treat HER2-positive cancers, and your doctor might recommend alternatives based on your specific situation. These alternatives work in different ways but target the same cancer pathway.

Pertuzumab is another HER2-targeted medication that's often used together with trastuzumab for more advanced cancers. T-DM1 (trastuzumab emtansine) combines trastuzumab with chemotherapy in one medication for certain situations.

Newer options include tucatinib and neratinib, which are oral medications that can be particularly helpful if cancer has spread to the brain. Your oncologist will consider factors like your cancer's specific characteristics and your overall health when choosing the best treatment approach.

Is Trastuzumab-DTTB Better Than Herceptin?

Trastuzumab-DTTB (Ogivri) works just as effectively as Herceptin, the original trastuzumab medication. Studies have shown that biosimilar medications like Ogivri provide the same cancer-fighting benefits with similar side effect profiles.

The main advantage of trastuzumab-DTTB is often cost savings for both you and the healthcare system. These savings can make treatment more accessible while maintaining the same high standard of care.

Your doctor will choose between these options based on factors like your insurance coverage, treatment center preferences, and availability. From a medical standpoint, both medications are considered equally effective for treating HER2-positive cancers.